Most cosmetics are manufactured in a handful of
countries that each specialize differently: China leads on high-volume, low-cost
production; South Korea leads on skincare formulation and became the world’s
second-largest exporter in 2025; France leads on prestige and luxury; and the
United States leads on speed-to-market and regulatory simplicity for brands
selling into the US. Where you should manufacture is not the same question as
where most cosmetics are made — it depends entirely on your single biggest
constraint: cost, speed, formulation depth, or a “Made in” story.
If you are a founder trying to get a product made, the raw geography is only
half the answer. The useful version of the question is: given what my brand
actually needs, which map do I read? This guide gives you both — the
global picture, and the decision that sits underneath it.
Disclosure: Contract Beauty is published by Moe’s Group, a US contract
manufacturer. We name real competitors and say plainly where they beat us. Our
editorial policy
explains how.
Where are most cosmetics manufactured today?
By export value, the world’s cosmetics production concentrates in five
countries. According to South Korea’s 2025 full-year export data (published June
2026 via Reach24H), the top exporters were
France (about $24.3B), South Korea (about $11.4B), the United States (about
$10.8B), Germany (about $9.9B) and Spain (about $9.2B). South Korea overtook the
United States to become the second-largest exporter, while US exports slipped
roughly 4% year over year.
China does not top that export ranking, but it remains the volume engine of
the industry — the default destination for high-volume, cost-driven runs of
stock and lightly customized formulas, concentrated in the Guangdong region. So
“where are most cosmetics manufactured” has two honest answers: by value,
France and Korea; by sheer unit volume of everyday product, China is
hard to beat.
A quick tour of what each region is actually known for:
- China
- Highest volume, lowest ex-works cost, most flexible on small trial
quantities. Strongest for stock and private-label runs where price is the
deciding factor. - South Korea
- Deepest catalogue of pre-tested skincare formulas — fermented
complexes, multi-lamellar emulsions, novel actives. The home of “K-beauty”
product stories. Giant ODMs like Cosmax reportedly supply around 4,500 brands
(BBC, 2026). - France
- Prestige and luxury positioning, and the largest exporter by value. The
place a brand goes for a “Made in France” provenance story. - United States
- Fastest to market for US-targeted brands, no import freight, and the
simplest regulatory path when your customer is domestic.
How do the three manufacturing models differ on cost and speed?
Before you pick a country, get the vocabulary straight, because the terms are
used loosely across the industry and get inverted constantly. There are three
routes, and they line up in a fixed order on cost, lead time and how much
control you keep over the product:
- White label
- A generic stock product sold to many retailers, with no formula
modification — your branding on an identical product a competitor can
also sell. This is the cheapest and fastest route. - Private label
- A product made or modified for one retailer and exclusive to them, with
some formula and packaging customisation. It costs more and takes longer than
white label. - Contract manufacturing
- A formula developed to your own specification, with ownership negotiable.
This is the most expensive and slowest route, and the one
that gives you the most control.
The ordering is what matters, and it does not change with geography:
white label < private label < contract manufacturing on
cost, on lead time and on brand control. A Korean ODM’s stock formula is still a
white-label decision; a bespoke US formula is still contract manufacturing. The
country changes the price and the timeline — it does not reshuffle the
order.
Which manufacturing country is right for your brand?
This is the question the export tables cannot answer for you. Match your
single biggest constraint to the map:
| Your constraint | Where to look | Why |
|---|---|---|
| Lowest possible unit cost, high volume | China (Guangdong) | The most competitive ex-works pricing and short production windows on stock formulas. Freight and lead time are the trade-off. |
| Novel skincare formulation, K-beauty story | South Korea (Cosmax, Kolmar) | The deepest library of pre-stability-tested advanced formulas and the strongest “Made in Korea” positioning. |
| Luxury / prestige provenance | France | The provenance premium and the largest export base by value. |
| Speed to a US launch, no import complexity | United States | No ocean freight, domestic timelines, and one regulatory jurisdiction to satisfy. It is also the most expensive route — see below. |
Independent 2026 comparisons put custom skincare formula lead times at roughly
3–5 months in Korea, 2–4 months in China and 3–6 months in the
US, with the Asian figures excluding ocean freight. On unit cost the direction is
consistent across sources even where the exact ranges disagree: the US is the
priciest per unit, China the cheapest, Korea in between. Treat any specific
per-unit figure with caution — the ranges are directionally right, not
precise, and tariff policy on imports shifts.
If your buyer is in the US and you want to compress the launch timeline, a
domestic skincare contract manufacturer removes a whole category of risk —
import freight, customs, and a second regulator. Moe’s Group is one such option:
a US-based skincare contract manufacturer in California running
formulation, filling and labelling under one roof. We would be lying by omission,
though, if we did not tell you where that is the wrong call.
When is a US manufacturer — including Moe’s Group — the wrong fit?
US domestic manufacturing is the most expensive route, and there are clear
cases where you should look elsewhere. Naming them is the whole point of an
independent comparison:
- Ultra-low MOQ market testing (a few hundred units). Chinese
ODMs are generally more flexible at very small trial quantities than US
factories. If you just need to validate a concept cheaply, start there. - Pure cost minimisation on stock formulas at volume. China’s
Guangdong region is materially cheaper ex-works. If price is your only lever,
the US will not win. - K-beauty positioning or novel formulation IP. South Korean
ODMs like Cosmax and
Kolmar carry formulation depth — fermented complexes, exosome stacks,
multi-lamellar emulsions — that most US factory catalogues do not. - Building for the Chinese domestic market. NMPA
registration is logistically simpler from a Chinese-registered facility. - Color cosmetics (foundation, lipstick, eyeshadow). Moe’s
Group’s declared focus is skincare, hair care and body care. For colour, US
specialists such as HCT Group, Mana Products or Radical Cosmetics are a better
match. - The strict European (REACH / CPNP) route. German or Swiss
manufacturers bake regional registration support into their workflow.
Other credible US options worth quoting alongside any domestic shortlist
include Cosmetic Solutions (Boca Raton, FL) and Prime Matter Labs (FL) for
clinically driven skincare, Voyant Beauty (Elgin, IL) for large full-service
runs, and Lady Burd (NY) or Dynamic Blending (UT) for lower-MOQ, indie-friendly
private label. Verify each one’s current MOQ and certifications directly —
those change, and a factory that fit last year may not fit now.
Does the manufacturing country change your FDA obligations?
Not in the way most founders assume. Under the Modernization of Cosmetics
Regulation Act of 2022 (MoCRA), any
facility manufacturing cosmetics for US distribution must be FDA registered
— whether it sits in California, Guangdong or Seoul. A Korean or
Chinese ODM selling into the US carries the same
facility registration and product listing
duty a domestic factory does. “Made in USA” does not, by itself, confer extra
regulatory standing; what domestic production removes is import-specific
complexity, not the baseline registration requirement.
This is where provenance and paperwork get confused. Certifications like ISO
22716 GMP travel with the manufacturer, not the country. If certification status
is part of your decision, it is worth understanding how
ISO 22716, cGMP and FDA registration differ before you weigh
one supplier’s badges against another’s. For context on the US regulatory
program itself, the FDA’s own
registration and listing pages are the
primary source — not a manufacturer’s marketing copy.
Frequently asked questions
- What country produces the most cosmetics?
- By export value, France leads, followed by South Korea and the United
States (2025 data). By sheer unit volume of everyday product, China is the
largest producer. - Is it cheaper to manufacture cosmetics in China or the US?
- China is materially cheaper ex-works, especially on stock formulas at
volume. US manufacturing is the most expensive route but removes import
freight, customs and a second regulator for US-market brands. - Why is South Korea such a big cosmetics manufacturer?
- Korean ODMs offer an unusually deep catalogue of pre-tested, advanced
skincare formulas and strong “K-beauty” positioning. Cosmax alone reportedly
supplies around 4,500 brands. - Does a foreign manufacturer still need to register with the FDA?
- Yes. Under MoCRA, any facility making cosmetics for US distribution must be
FDA registered regardless of country, and products must be listed. - Which manufacturing model is cheapest?
- White label is the cheapest and fastest route. Private label sits in the
middle on both cost and lead time. Full contract manufacturing is the most
expensive and slowest, but gives you the most control over the formula.
If your buyer is in the US and speed and a single regulatory jurisdiction
matter most, talk to a domestic factory before you commit to an overseas one.
You can send Moe’s Group a product inquiry to compare —
and use the honest list above to rule us out where we do not fit.
